GM-CSF in Treating Patients With Relapsed Prostate Cancer

Summary

RATIONALE: Colony stimulating factors, such as GM CSF, may increase the number of immune cells found in bone marrow or peripheral blood. It is not yet known which GM-CSF regimen is more effective in treating patients with prostate cancer. PURPOSE: This randomized phase II trial is studying how well GM-CSF works in treating patients with relapsed prostate cancer.

Timeline

Start

2006-06

Primary completion

2010-06

Completion

2010-07

Drugs

Indications